TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
Manufacturer adverse-event records for TERUMO CARDIOVASCULAR SYSTEMS CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2000–2026 · thin-book · typical Death-code · injury-light
Injury-mix signature
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION is lighter on Injury codes
Injury-coded event_type share is 4.6% (injury-light tercile) beside 0.70% Death-coded (typical). Volume band: thin.
What the Injury-mix reading shows for TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
The standout signal for TERUMO CARDIOVASCULAR SYSTEMS CORPORATION is Injury-mix: 4.6% Injury-coded (injury-light) beside 0.70% Death-coded, on a thin-book footprint.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 20 device types, led in this extract by Malfunction at 7,242 (92.7% of event_type total). Peak single-year volume reaches 1,049 reports across 27 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.